Targeting invariant natural killer T (iNKT) cells could be a good way to boost vaccine responses, according to recent studies reviewed here. Structural and functional analyses of iNKT-cell ligands are helping to direct approaches that harness the capacity of iNKT cells to enhance immune responses.
- Vincenzo Cerundolo
- Jonathan D. Silk
- Mariolina Salio
